Intranasal butorphanol rescue therapy for the treatment of intractable pruritus: A case series from the Johns Hopkins Itch Clinic - 10/10/20
Authors Khanna and Kwon contributed equally to this manuscript as cofirst authors. |
|
Funding sources: Dr Kwatra has received the Dermatology Foundation Medical Dermatology Career Development Award. |
|
Conflicts of interest: Dr Kwatra is on the scientific advisory board for Incyte Corporation, Pfizer Inc, Regeneron Pharmaceuticals, and Menlo Therapeutics and has received grant funding from Galderma SA, Kiniksa Pharmaceuticals, and Pfizer Inc. Authors Khanna, Khanna, and Williams and Drs Kwon, Patel, Belzberg and Boozalis have no conflicts of interest to declare. |
|
IRB approval status: Approval was granted by the Johns Hopkins Medicine Institutional Review Board. Patient consent was not required. |
|
Reprints not available from the author(s). |
Vol 83 - N° 5
P. 1529-1533 - novembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?